Spironolactone Tablet, Film Coated
Product Images NDC 51655-861

4 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 51655-861). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)
Chemical structure of spironolactone. The image depicts the molecular structure, showing the steroid backbone with characteristic rings and attached functional groups, representing the active ingredient spironolactone.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)
A Kaplan-Meier survival curve comparing Spironolactone and Placebo groups over a 42-month period. The graph shows probability on the y-axis and months on the x-axis, with Spironolactone group represented by a dotted line and Placebo by a solid line. The Spironolactone group has a higher survival probability. Sample sizes are 822 for Spironolactone and 841 for Placebo.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)
A forest plot chart depicting the hazard ratios (HR) and 95% confidence intervals (CI) for different subgroups in a study comparing spironolactone versus placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, and medication use (digoxin, ACE inhibitors, beta blockers). The horizontal axis measures relative benefit from spironolactone to placebo.*
FDA Label Image

Label (51655 861 26 Rev B 08 23 Nhc)

Label (51655 861 26   Rev B 08 23 Nhc)
Spironolactone Tablets USP 50 mg film-coated tablets packaging label from Northwind Health Company, LLC. The label indicates a bottle containing 90 tablets, prescription use only, with storage instructions to keep at 20°-25°C and protect from light. The label includes dosing and safety warnings as well as NDC 51655-861.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.